Norihiko Funaguchi

506 total citations
36 papers, 377 citations indexed

About

Norihiko Funaguchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Norihiko Funaguchi has authored 36 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in Norihiko Funaguchi's work include Nausea and vomiting management (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Norihiko Funaguchi is often cited by papers focused on Nausea and vomiting management (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Norihiko Funaguchi collaborates with scholars based in Japan and Spain. Norihiko Funaguchi's co-authors include Shinya Minatoguchi, Yasushi Ohno, Kozo Kuribayashi, Takashi Nakano, Takako Fujiwara, Hisayoshi Fujiwara, Genzou Takemura, Toshihiro Asai, Masahiro Sawada and Hirotoshi Iihara and has published in prestigious journals such as The Oncologist, BMJ Open and Biological and Pharmaceutical Bulletin.

In The Last Decade

Norihiko Funaguchi

32 papers receiving 370 citations

Peers

Norihiko Funaguchi
Jeremy S. Haley United States
Huzi Xu China
Jenny Sherriff United Kingdom
David M. Gustin United States
N. Lee United States
Norihiko Funaguchi
Citations per year, relative to Norihiko Funaguchi Norihiko Funaguchi (= 1×) peers Naveen K. Krishnegowda

Countries citing papers authored by Norihiko Funaguchi

Since Specialization
Citations

This map shows the geographic impact of Norihiko Funaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihiko Funaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihiko Funaguchi more than expected).

Fields of papers citing papers by Norihiko Funaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihiko Funaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihiko Funaguchi. The network helps show where Norihiko Funaguchi may publish in the future.

Co-authorship network of co-authors of Norihiko Funaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Norihiko Funaguchi. A scholar is included among the top collaborators of Norihiko Funaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihiko Funaguchi. Norihiko Funaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funaguchi, Norihiko, et al.. (2023). Primary Squamous Cell Lung Cancer With Frequent Episodes of Sustained Ventricular Tachycardia due to Myocardial Metastasis. Journal of Medical Cases. 14(4). 111–117.
2.
Shimokawa, Mototsugu, Hirotoshi Iihara, Yukiyoshi Fujita, et al.. (2021). Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial. The Oncologist. 26(6). e1066–e1072. 5 indexed citations
3.
Sasaki, Yuka, et al.. (2019). Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer. Respiratory Medicine Case Reports. 28. 100871–100871. 22 indexed citations
4.
Iihara, Hirotoshi, Mototsugu Shimokawa, Yukiyoshi Fujita, et al.. (2019). Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial. BMJ Open. 9(7). e028056–e028056. 1 indexed citations
5.
Kuribayashi, Kozo, Norihiko Funaguchi, Koji Mikami, et al.. (2019). Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases. In Vivo. 33(2). 507–514. 8 indexed citations
6.
Iihara, Hirotoshi, Norihiko Funaguchi, Justin Endo, et al.. (2019). Prophylactic effect of rikkunshito, an herbal medicine, for chemotherapy-induced nausea in thoracic cancer patients receiving carboplatin-based chemotherapy.. PubMed. 74(10). 620–624. 3 indexed citations
7.
Kuribayashi, Kozo, Norihiko Funaguchi, Hiroshi Doi, et al.. (2018). Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. In Vivo. 32(5). 1169–1174. 7 indexed citations
8.
Iihara, Hirotoshi, Norihiko Funaguchi, Yuka Sasaki, et al.. (2017). Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based Chemotherapy. Anticancer Research. 37(4). 1965–1970. 1 indexed citations
9.
Minatoguchi, Shinya, et al.. (2016). 3-D computed tomographic airway analysis detects mild bronchiectasis in mycobacterium avium complex pulmonary disease. 9(3). 5978–5986.
10.
Kanemura, Shingo, Kozo Kuribayashi, Norihiko Funaguchi, et al.. (2016). Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma. European Journal of Radiology. 86. 92–98. 9 indexed citations
11.
Kuribayashi, Kozo, Norihiko Funaguchi, & Takashi Nakano. (2016). Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma. Journal of Cancer Research and Therapeutics. 12(2). 528–534. 51 indexed citations
12.
Kuribayashi, Kozo, Shinichiro Iida, Y. Nakajima, et al.. (2015). Suppression of heme oxygenase-1 activity reduces airway hyperresponsiveness and inflammation in a mouse model of asthma. Journal of Asthma. 52(7). 662–668. 13 indexed citations
13.
Iihara, Hirotoshi, et al.. (2012). A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy.. PubMed. 32(9). 3939–47. 7 indexed citations
14.
Mori, Hideki, et al.. (2010). Polymerase Chain Reaction Positivity of Pneumocystis jirovecii During Primary Lung Cancer Treatment. Japanese Journal of Clinical Oncology. 40(7). 658–662. 6 indexed citations
15.
Ohno, Yasushi, Yusuke Tsuge, Masanori Kawasaki, et al.. (2009). Use of Multidetector Row CT to Evaluate the Need for Bronchial Arterial Embolization in Hemoptysis Patients. Respiration. 80(1). 24–31. 32 indexed citations
16.
Ohno, Yasushi, et al.. (2009). Effect of Intermittent Systemic Corticosteroid on Bone Metabolism in Bronchial Asthma Patients. Journal of Asthma. 46(2). 142–146. 9 indexed citations
17.
Ohno, Yasushi, et al.. (2009). Massive Hematuria from the Bilateral Upper Urinary Tract in a Patient Treated for Advanced Lung Cancer with Gefitinib. Japanese Journal of Clinical Oncology. 40(3). 263–266. 4 indexed citations
18.
Sawada, Masahiro, Yasushi Ohno, Norihiko Funaguchi, et al.. (2007). THE FAS/FAS-LIGAND PATHWAY DOES NOT MEDIATE THE APOPTOSIS IN ELASTASE-INDUCED EMPHYSEMA IN MICE. Experimental Lung Research. 33(6). 277–288. 12 indexed citations
19.
Funaguchi, Norihiko, Yasushi Ohno, Toshihiro Asai, et al.. (2007). NARIRUTIN INHIBITS AIRWAY INFLAMMATION IN AN ALLERGIC MOUSE MODEL. Clinical and Experimental Pharmacology and Physiology. 34(8). 766–770. 79 indexed citations
20.
Ohno, Yasushi, Norihiko Funaguchi, Toshihiro Asai, et al.. (2006). BENEFICIAL EFFECTS OF AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION AGAINST ELASTASE-INDUCED EMPHYSEMA IN RABBITS. Experimental Lung Research. 32(9). 413–426. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026